| [18F] DCFPyL PET/CT imaging in prostate cancer patients: a prospective study on safety, lesion detection rate, and impact on management E Rousseau, D Wilson, A Krauze, K Chi, M Gleave, M McKenzie, ... Journal of Nuclear Medicine 60 (supplement 1), 651-651, 2019 | | 2019 |
| 1065 PREDICTORS OF ONCOLOGIC OUTCOMES AFTER SALVAGE RADICAL PROSTATECTOMY FOR RADIO-RECURRENT PROSTATE CANCER: A MULTI-INSTITUTIONAL COLLABORATION D Chade, SF Shariat, AM Cronin, RJ Karnes, ML Blute, A Briganti, ... The Journal of Urology 183 (4S), e415-e415, 2010 | | 2010 |
| 1080 A PROSPECTIVE RANDOMIZED TRIAL OF POVIDONE-IODINE PROPHYLACTIC CLEANSING OF THE RECTUM PRIOR TO TRANSRECTAL ULTRASOUND-GUIDED PROSTATE BIOPSY Z Abughosh, J Margolick, SL Goldenberg, K Afshar, S Taylor, D Lange, ... The Journal of Urology 187 (4S), e438-e439, 2012 | | 2012 |
| 1088: Novel Bispecific Antisense Oligonucleotides Inhibiting both BCL-2 and BCL-XL Expression Induce Apoptosis and Enhance Chemosensitivity in Human Androgen-Independent … K Yamanaka, H Miyake, U Zangemeister-Wittke, B Jansen, ME Gleave The Journal of Urology 171 (4S), 287-287, 2004 | | 2004 |
| 1093 An international multi-center study examining re-classification rates of patients with prostate cancer suitable active surveillance whom underwent radical prostatectomy LM Wong, R Johnston, DE Neal, A Warren, N Shah, C Hovens, ... European Urology Supplements 1 (11), e1093, e1093a, 2012 | | 2012 |
| 1096 the ability of PSA density to predict an upgrade in Gleason score between initial prostate biopsy and prostatectomy diminishes with increasing tumour grade due to lower … N Corcoran, C Hovens, M Hong, M Gleave, A Costello, L Goldenberg The Journal of Urology 185 (4S), e441-e441, 2011 | 1 | 2011 |
| 1096 THE ABILITY OF PSA DENSITY TO PREDICT AN UPGRADE IN GLEASON SCORE BETWEEN INITIAL PROSTATE BIOPSY AND PROSTATECTOMY DIMINISHES WITH INCREASING TUMOUR GRADE DUE TO LOWER … N Corcoran, C Hovens, M Hong, M Gleave, A Costello, L Goldenberg JOURNAL OF UROLOGY 200 (3), e441-e441, 2018 | | 2018 |
| 1121: The Cytoprotective Chaperone, Clusterin, is Associated with Docetaxel-Resistance in Prostate Cancer Cell Lines: Implications in Second-Line Strategies for Metastatic HRPC RD Sowery, BA Hadaschik, L Fazli, S Ettinger, AI So, ME Gleave The Journal of Urology 177 (4S), 370-370, 2007 | | 2007 |
| 1126: HSP27 Controls Cell Growth and Apoptosis in LNCAP Cells by Regulating the Anti-Apoptotic Phosphoprotein, PEA-15 N Hayashi, E Beraldi, J Peacock, A Zoubeidi, C Ong, ME Gleave The Journal of Urology 177 (4S), 372-372, 2007 | | 2007 |
| 1137: Antisense Inhibition of Clusterin Enhances Apoptotic Cell Death in Human Prostate Cancer Cells through not Only Down-Regulation of Anti-Apoptotic Clusterin Isoform but Up … M Muramaki, C Nelson, H Miyake, M Fujisawa, ME Gleave The Journal of Urology 177 (4S), 375-375, 2007 | | 2007 |
| 1142: Multicenter Phase II Study of Combined Neoadjuvant Docetaxel and Hormone Therapy Prior to Radical Prostatectomy for Patients with High Risk Localized Prostate Cancer … ME Gleave, K Chi, JL Chin, E Winquist, LH Klotz, S Berry, D Ruether, ... The Journal of Urology 177 (4S), 377-377, 2007 | | 2007 |
| 1187 THE EFFECT OF A SELECTIVE AKT SMALL MOLECULE INHIBITOR, GSK690693C, IN PROSTATE CANCER CELLS IN VITRO AND IN VIVO N Hayashi, A Zoubeidi, C Ong, M Gleave The Journal of Urology 183 (4S), e459-e460, 2010 | | 2010 |
| 125 CLUSTERIN ANTISENSE INHIBITOR OGX-011 SYNERGIZES ACTIVITY OF SECOND GENERATION ANTI-ANDROGEN, MDV3100, IN CASTRATE RESISTANT PROSTATE CANCER MODEL H Matsumoto, H Kuruma, A Zoubeidi, L Fazli, M Gleave The Journal of Urology 185 (4S), e52-e53, 2011 | | 2011 |
| 1279 CLU INHIBITION USING OGX-011 IS A NEW ADJUVANT THERAPEUTIC STRATEGY FOR HSP90 INHIBITION IN PROSTATE CANCER F Lamoureux, MJ Yin, A Zoubeidi, M Gleave JOURNAL OF UROLOGY 200 (3), e512-e512, 2018 | | 2018 |
| 1279 CLU INHIBITION USING OGX-011 IS A NEW ADJUVANT THERAPEUTIC STRATEGY FOR HSP90 INHIBITION IN PROSTATE CANCER F Lamoureux, MJ Yin, A Zoubeidi, M Gleave The Journal of Urology 185 (4S), e512-e512, 2011 | | 2011 |
| 1293 A NOVEL ANTI-ANDROGEN ARD1 DOWN-REGULATES ANDROGEN RECEPTOR LEVELS AND ACTIVITY AND SUPPRESSES PROSTATE CANCER LNCAP CELL GROWTH IN VITRO AND IN VIVO H Kuruma, K Gust, H Matsumoto, A Zoubeidi, L Fazli, S Loddick, N Brooks, ... The Journal of Urology 183 (4S), e500-e500, 2010 | | 2010 |
| 1298 THE NOVEL HSP90 INHIBITOR, PF-04929113, INHIBITS AR ACTIVITY AND OSTEOCLASTOGENESIS AND DELAYS CASTRATE RESISTANT LNCAP PROSTATE CANCER TUMOR GROWTH F Lamoureux, MJ Yin, A Zoubeidi, M Gleave The Journal of Urology 183 (4S), e502-e502, 2010 | | 2010 |
| 138 Exploring a novel therapeutic target for neuroendocrine prostate cancer using a xenograft model of trans-differentiation S Akamatsu, A Wyatt, D Lin, S Lysakowski, F Zhang, Y Kawai, L Fazli, ... European Urology Supplements 3 (15), e138, 2016 | | 2016 |
| 146: Clusterin is a Ubiquitin Binding Protein Involved in Murr1 and 1-KB Proteasomal Degradation to Confer Cell Survival in Prostate Cancer A Zoubeidi, E Beraldi, A Zardan, ME Gleave The Journal of Urology 177 (4S), 50-50, 2007 | | 2007 |
| 1492 BIOCHEMICAL PROGRESSION FREE SURVIVAL AFTER RADICAL PROSTATECTOMY IN MEN WITH HIGH-RISK CLINICALLY LOCALISED PROSTATE CANCER J Ischia, L Goldenberg, A So, P Black, M Gleave The Journal of Urology 189 (4S), e611-e611, 2013 | | 2013 |
